Healthcare & Life Sciences
I-Mab
China
series-c-plus
series-c-plus
Stage
2
Investors
About
I-Mab is a clinical-stage biopharmaceutical company focused on developing innovative biologics for the treatment of oncology and autoimmune diseases.
Explore I-Mab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.